Advert Occasional acid reflux is normal and manageable according to the Cleveland Clinic, but ‘chronic acid reflux (GERD) might need treatment'. The medical center added: “When acid creeps into places ...

That’s acid reflux, a common digestive discomfort, occurs when stomach acid flows back into the esophagus, triggering the ...

While most episodes of vomiting don't lead to Boerhaave syndrome, it is a rare possibility, and vomiting can cause other ...

BE is the only known precursor to esophageal cancer. The condition is caused by prolonged exposure of the esophagus to ...

Cancer plasticity allows tumor cells to change their identity, evade therapies, and adapt to environmental pressures, contributing to treatment resistance and metastasis. New research is targeting ...

Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and ...

Oesophageal cancer, namely oesophageal adenocarcinoma, remains extremely difficult to treat with an overall 5-year survival of approximately 20 %. The modern contest remains between trimodal ...

This is the first randomised controlled trial of CAR T-cell therapy in solid tumours globally. Satri-cel treatment resulted in a significant improvement in progression-free survival, with a manageable ...

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth up to $25 billion.

The researchers note that as of June 2024, 144 out of 187 precision cancer treatments were only FDA-approved for adults. Similar patterns are present in the European Union and Japan.

Researchers may have come up with an interesting new treatment for cancer by talking to AI. According to a paper published this month, a research team led by the University of Cambridge turned to ...

In an opinion paper published in the journal Trends in Cancer, oncologists call for "ag(e)nostic" cancer treatments: drugs that are both tissue agnostic and approved for cancer patients of all ages.